Page 190 - Haematologica June

1092
J. Hrdinová et al.
topenic purpura in Caucasians. J Thromb
Haemost. 2010;8(4):856-859.
16. Scully M, Brown J, Patel R, Mcdonald V,
Brown CJ, Machin S. Human leukocyte antigen association in idiopathic thrombot- ic thrombocytopenic purpura: Evidence for an immunogenetic link. J Thromb Haemost. 2010;8(2):257-262.
17. John M-LL, Hitzler W, Scharrer I. The role of human leukocyte antigens as predispos- ing and/or protective factors in patients with idiopathic thrombotic thrombocy- topenic purpura. Ann Hematol. 2012;91(4): 507-510.
18. Mancini I, Ricaño-Ponce I, Pappalardo E, et al. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura. J Thromb Haemost. 2016;14(12):2356-2367.
19. Sorvillo N, van Haren SD, Kaijen PHP, et al. Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells. Blood. 2013;121(17):3502-3510.
20. Verbij FC, Turksma AW, de Heij F, et al. CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura rec- ognize CUB-2 domain derived peptides. Blood. 2016;127(12):1606-1609.
21. Gilardin L, Delignat S, Peyron I, et al. The ADAMTS13(1239-1253) peptide is a domi- nant HLA-DR1-restricted CD4+ T-cell epi- tope. Haematologica. 2017;102(11):1833- 1841.
22. Spits H, Keizer G, Borst J, Terhorst C, Hekman A, de Vries JE. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activi- ty of natural and activated killer cells and cloned CTL lines. Hybridoma. 1983; 2(4):423-437.
23. van Haren SD, Herczenik E, ten Brinke A, Mertens K, Voorberg J, Meijer AB. HLA- DR-presented Peptide Repertoires Derived From Human Monocyte-derived Dendritic Cells Pulsed With Blood Coagulation Factor VIII. Mol Cell Proteomics 2011; 10(6):M110.002246.
24. Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in pro- teomics. Anal Chem. 2003;75(3):663-670.
25. Peyron I, Hartholt RB, Pedró-Cos L, et al. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells. Haematologica. 2018;103(1):172-178.
26. Karosiene E, Rasmussen M, Blicher T, Lund O, Buus S, Nielsen M. NetMHCIIpan-3.0, a common pan-specific MHC class II predic- tion method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics. 2013; 65(10):711-724.
27. De Groot AS, Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol. 2009;131(2):189-201.
reverse transcriptase-polymerase chain reaction (RT-PCR). Eur J Immunogenet. 2003;30(2):141-148.
36. Rieger M, Ferrari S, Kremer Hovinga JA, et al. Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA). Thromb Haemost. 2006;95(2):212-220.
37. Sorvillo N, Pos W, van den Berg LM, et al. The macrophage mannose receptor pro- motes uptake of ADAMTS13 by dendritic cells. Blood. 2012;119(16):3828-3835.
38. Verbij FC, Sorvillo N, Kaijen PHP, et al. The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages. Blood Adv. 2017;1(5):293-
28. Moise L, Gutierrez AH, Bailey-Kellogg C,
et al. The two-faced T cell epitope. Hum 305.
Vaccin Immunother. 2013;9(7):1577-1586. 29. Liu R, Moise L, Tassone R, et al. H7N9 T- cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance. Hum Vaccin
Immunother. 2015;11(9):2241-2252.
30. Losikoff PT, Mishra S, Terry F, et al. HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. J Hepatol.
2015;62(1):48-55.
31. de Verteuil D, Muratore-Schroeder TL,
Granados DP, et al. Deletion of immuno- proteasome subunits imprints on the tran- scriptome and has a broad impact on pep- tides presented by major histocompatibili- ty complex I molecules. Mol Cell Proteomics. 2010;9(9):2034-2047.
32. Wahlström J, Dengjel J, Persson B, et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest. 2007;117(11):3576-3582.
33. Fissolo N, Haag S, de Graaf KL, et al. Naturally presented peptides on major his- tocompatibility complex I and II molecules eluted from central nervous system of mul- tiple sclerosis patients. Mol Cell Proteomics. 2009;8(9):2090-2101.
34. Brooks CF, Moore M. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells. Immunology. 1988;63(2):303-311.
35. Fernandez S, Wassmuth R, Knerr I, Frank C, Haas JP. Relative quantification of HLA- DRA1 and -DQA1 expression by real-time
39. Sorvillo N, Kaijen PHP, Matsumoto M, et al. Identification of N-linked glycosylation and putative O-fucosylation, C-mannosylation sites in plasma derived ADAMTS13. J Thromb Haemost. 2014;12(5):670-679.
40. Verbij FC, Stokhuijzen E, Kaijen PHP, van Alphen F, Meijer AB, Voorberg J. Identification of glycans on plasma-derived ADAMTS13. Blood. 2016;128(21):e51-e58.
41. Nicolaes GAF, Villoutreix BO, Dahlbäck B. Partial glycosylation of Asn2181 in human factor V as a cause of molecular and func- tional heterogeneity. Modulation of glyco- sylation efficiency by mutagenesis of the consensus sequence for N-linked glycosyla- tion. Biochemistry. 1999;38(41):13584- 13591.
42. Enouz S, Carrié L, Merkler D, Bevan MJ, Zehn D. Autoreactive T cells bypass nega- tive selection and respond to self-antigen stimulation during infection. J Exp Med. 2012;209(10):1769-1779.
43. Dzhambazov B, Holmdahl M, Yamada H, et al. The major T cell epitope on type II colla- gen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur J Immunol. 2005;35(2):357-366.
44. Yamada H, Dzhambazov B, Bockermann R, Blom T, Holmdahl R. A transient post- translationally modified form of cartilage type II collagen is ignored by self-reactive T cells. J Immunol. 2004;173(7):4729-4735.
45. Purcell AW, van Driel IR, Gleeson PA. Impact of glycans on T-cell tolerance to gly- cosylated self-antigens. Immunol Cell Biol. 2008;86(7):574-579.
haematologica | 2018; 103(6)